Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)-a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data.
Phillip M FreemanMajd B ProttyOmar AldalatiArron LaceyWilliam KingRichard A AndersonDave SmithPublished in: Open heart (2016)
TAVI patients were more likely to survive and avoid hospital admissions compared with the medically managed STD group. The ICER for TAVI was £10 533 per QALY, making it a cost-effective procedure.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- ejection fraction
- aortic valve replacement
- aortic valve
- transcatheter aortic valve replacement
- left ventricular
- end stage renal disease
- healthcare
- chronic kidney disease
- newly diagnosed
- quality improvement
- peritoneal dialysis
- minimally invasive
- type diabetes
- cross sectional
- artificial intelligence
- data analysis
- glycemic control
- insulin resistance
- bone marrow
- atrial fibrillation
- deep learning